Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001355758-26-000007

Options or other derivatives

  • Director acquired 38,040 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Castelein Caley · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-12 Grant or award : show line 1 in the form Stock Option (right to buy) +38,040 38,040 D
Loading xslF345X06/form4-06152026_090621.xml…